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The case of a 23-year-old female treated with aggressive high-dose therapy for Burkitt’s lymphoma is reported. A positron 
emission tomography and computed tomography scan after completion of chemotherapy revealed a residual hypermeta-
bolic lesion in the right pelvic cavity. A pelvic magnetic resonance imaging scan showed circumferential wall thickening 
at the tip of the appendix. A laparoscopic exploration and appendectomy were performed, and a pathologic examination 
of the resected appendix revealed xanthogranulomatous appendicitis. This is a rare case of a xanthogranulomatous appen-
dicitis mimicking remnant Burkitt’s lymphoma after completion of chemotherapy.
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INTRODUCTION
Burkitt’s lymphoma was first described in 1958 as a highly-aggres-
sive B-cell non-Hodgkin’s lymphoma characterized by monomor-
phic medium-sized cells. It is the most prevalent type of lym-
phoma in children [1]. The most commonly involved site in cases 
of sporadic Burkitt’s lymphoma is the abdomen [2]. Because of 
the abundant lymphoid tissue, the ileocolic region is the most 
common site affected in children younger than 16 years of age. 
Burkitt’s lymphoma in adults is uncommon and typically presents 
with symptoms of rapidly developing disease, most commonly in 
the abdomen. The chemotherapy regimen generally used for 
adults includes cyclophosphamide, vincristine, doxorubicin, and 
high-dose methotrexate alternating with ifosfamide, etoposide, 
and high-dose cytarabine [1]. Magrath et al. [3] reported an 89% 
2-year survival rate among 54 adult patients. Because Burkitt’s 
lymphoma produces a very high signal on fluorodeoxyglucose 
positron emission tomography (PET) scans, PET is a valuable 
tool for detection of disease recurrence [4].
Xanthogranulomatous appendicitis is a rare phenomenon, with 
only 10 cases having been reported to date in the English litera-
ture [5]. In cases of acute appendicitis, xanthogranulomatous in-
flammation is more commonly seen with delayed appendectomy 
[6]. Typically, xanthogranulomatous inflammation is found in the 
kidneys, gallbladder, lungs, and prostate [7]. Xanthogranuloma-
tous appendicitis can be misdiagnosed as remnant malignancy, 
which may lead to unnecessary further treatment. We report a 
rare case of xanthogranulomatous appendicitis mimicking rem-
nant Burkitt’s lymphoma on radiologic studies. 
CASE REPORT
In March 2013, a 23-year-old woman was admitted to our hospi-
tal for low abdominal pain. PET and computed tomography (CT) 
scans revealed conglomerated, vessel-encasing hypermetabolic 
masses extending from the midabdomen into the pelvic cavity. 
The mass partially encased the terminal ileum without obstruc-
tion (Fig. 1). An ultrasound-guided biopsy was performed, and 
immunohistochemical staining was positive for CD20, CD10, 
and Bcl-6 and negative for CD3, Bcl-2, CD30, and MUM-1. Ki67 
L.I. was nearly 100%. A pathologic diagnosis of malignant 
Burkitt’s lymphoma was made.
In April 2013, R-hyper cyclophosphamide, vincristine, doxoru-
bicin, dexamethasone (CVAD) chemotherapy was initiated in this 
patient. Cyclophosphamide, vincristine, doxorubicin, dexametha-
sone, cytarabine, mesna, and methotrexate were given during the 
odd cycles. Methotrexate, leucovorin, sodium bicarbonate, and 
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cytarabine were given during the even cycles. A total of 8 cycles of 
R-hyper CVAD chemotherapy were given until November 2013. 
After termination of chemotherapy, another PET-CT scan was 
obtained in December 2013 and showed a residual hypermeta-
bolic lesion in the right pelvic cavity (Fig. 2). Because fluodeoxy-
glucose (FDG) uptake can be interpreted as physiologic uptake, 
we opted for reevaluation after 3 weeks. However, there was no 
change in the hypermetabolic lesion. Pelvic magnetic resonance 
imaging (MRI) was subsequently performed for further evalua-
tion (Fig. 3) and revealed circumferential wall thickening at the 
tip of the appendix, suggesting either chronic appendicitis or the 
formation of a mucocele or regressed lymphoma.
The patient was referred to the Department of Surgery, and a 
laparoscopic exploration was performed. Some adhesions were 
found between the mesoappendix and the mesentery of the ter-
minal ileum. Fibrotic scar tissue, suggesting regression of a lym-
phoma, was also detected in the lower pelvic cavity. An enlarge-
ment of the appendiceal tip, which looked consistent with a rem-
nant lymphoma, was onserved. A small mass near the appendix, 
which was presumed to be a lymph node, was excised along with 
the appendix. The specimen was sent for histopathologic evalua-
tion, and the patient’s postoperative course was uncomplicated. 
The final pathology of the specimen revealed a xanthogranulo-
matous appendicitis, with no evidence of a remnant lymphoma. 
The small mass near the appendix was identified as a foamy his-
Fig. 1. (A-D) Positron emission tomography and computed tomography images at the time of diagnosis showed a hypermetabolic mass sug-
gestive of a lymphoma in the midabdomen and the pelvic cavity.
A
C
B
D
Fig. 2. Positron emission tomography scan after completion of ag-
gressive high-dose chemotherapy showed a residual hypermetabolic 
lesion (arrow) in the right pelvic cavity.
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tiocytic collection (Fig. 4). No further evaluation or treatment was 
required, though the patient was scheduled for regular follow-up. 
 
DISCUSSION
Burkitt’s lymphoma typically presents with a bulky abdominal 
mass, B symptoms, and laboratory evidence of tumor lysis [8]. 
Prompt diagnosis and initiation of appropriate therapy are neces-
sary for optimal results, as complete regression of a lymphoma is 
important for long-term survival [9]. Relapses of Burkitt’s lym-
phoma, which most commonly occur within 6 months of com-
pletion of treatment, are associated with poor outcomes [1]. In 
clinical practice, remnant masses have been observed on imaging 
studies after completion of intensive chemotherapy in several 
cases [10, 11]. Son et al. [11] reported a case of ectopic thymic hy-
perplasia after chemotherapy for Burkitt’s lymphoma. Karmazyn 
et al. [10] reported 7 patients with residual abdominal masses 
among 33 children with abdominal Burkitt’s lymphoma who were 
confirmed to be in complete remission after chemotherapy. Com-
plete remission was defined as complete disappearance of all mea-
surable lesions with no blasts in the bone marrow or cerebrospi-
nal fluid. Among those seven patients, 2 underwent a second-
look surgery. The final pathologic diagnosis was fibrosis with no 
evidence of a viable tumor. The remaining five patients were 
closely followed, and most of the masses showed spontaneous re-
gression [10]. Among those 7 patients, none relapsed. In this 
study, the main diagnostic tool was CT and/or ultrasonography, 
though differentiating viable tumors and fibrosis by using these 
imaging modalities is sometimes difficult. Nowadays, the PET 
scan is regarded as a valuable tool for the detection of disease re-
currence [4]. 
In our case, the high FDG uptake on the PET-CT scan after che-
motherapy led us to suspect a remnant lymphoma. In addition, a 
follow-up MRI scan could not discriminate a regressed lym-
phoma from other benign conditions such as mucoceles or 
chronic appendicitis. Thus, surgical exploration was inevitable. 
Fig. 4. The specimen exhibited a foamy, full thickness histiocytic 
collection consistent with xanthogranulomatous appendicitis (A: 
H&E, ×200) and positive in histiocytes (B: CD68, ×200).
A
B
Fig. 3. Pelvic magnetic resonance imaging revealed circumferential 
wall thickening at the tip of the appendix, suggesting chronic appendi-
citis or the formation of a mucocele or regressed lymphoma. (A) Axial 
image of appendix (arrow). (B) Coronal image of appendix (arrow).
A
B
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Xanthogranulomatous inflammation is a very rare pathologic 
finding and has been reported to occur in the kidneys, gallblad-
der, urinary bladder, thyroid, endometrium, adrenal glands, and 
fallopian tubes [12]. The pathogenesis of xanthogranulomatous 
inflammation is still unknown. However, xanthogranulomatous 
change is suspected to be the result of hemorrhage, immunologi-
cal disorders, bacterial infection, reactions to specific infectious 
agents, and/or lymphatic obstruction [6, 12, 13]. Xanthogranulo-
matous change in the appendix is typically due to a long-standing 
or recurrent inflammatory process. Guo and Greenson [6] re-
ported that in interval appendectomy specimens, granulomatous 
inflammation, xanthogranulomatous inflammation, and Crohn’s-
like changes were more common than they were in acute appen-
dectomy specimens.
When the proximity of the primary mass to the appendix at the 
time of initial diagnosis is considered, xanthogranuloma appendi-
citis may be due to a residual change in the appendix after chemo-
therapy. However, the exact pathogenesis in these cases remains 
unclear. In addition, the FDG uptake of xanthogranulomatous 
appendicitis was difficult to distinguish from that of the suspected 
remnant lesions after chemotherapy for Burkitt’s lymphoma. In 
conclusion, xanthogranulomatous appendicitis is a rare disease 
that is difficult to diagnose on imaging studies alone.
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